ACR and acute myeloid leukemia: Our results show that AML and CYT significantly decreased the percentage of tubules with more than 15 ACROSIN-positive cells 1 and 2.5 weeks post AML and 2–2.5 weeks post-CYT treatment compared to the control group (Figure 5C).